Significant Ownership of GV 2019, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for GV 2019, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Mountain View, CA
- Manager signature
- /s/ Inga Goldbard - Inga Goldbard/General Counsel of GV 2019 GP, L.L.C., the General Partner of GV 2019 GP, L.P., its General Partner
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow GV 2019, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from GV 2019, L.P.
Significant Ownership of GV 2019, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Common Stock, par value $0.00001 per share | 12% | $91,756,239 | 16,562,498 | Alphabet Holdings LLC | 30 Sep 2025 | ||
| LIFE | ETHOS TECHNOLOGIES INC. | Class A Common Stock, par value $0.0001 per share | 12% | $67,787,405 | 3,770,156 | Alphabet Holdings LLC | 31 Mar 2026 | ||
| MAZE | MAZE THERAPEUTICS, INC. | Common Stock, par value $0.001 per share | 2.9% | $57,528,994 | -$42,419,680 | 1,388,583 | -42% | Alphabet Holdings LLC | 31 Dec 2025 |
Schedules 13D/G Reported by GV 2019, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.